Latest & greatest articles for hepatitis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hepatitis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hepatitis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hepatitis

41. Sorafenib is more effective in the treatment of TACE-refractory hepatocellular carcinoma than hepatic arterial infusion chemotherapy: a meta-analysis Full Text available with Trip Pro

Sorafenib is more effective in the treatment of TACE-refractory hepatocellular carcinoma than hepatic arterial infusion chemotherapy: a meta-analysis Sorafenib is more effective in the treatment of TACE-refractory hepatocellular carcinoma than hepatic arterial infusion chemotherapy: a meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer (...) review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research Sorafenib is more effective in the treatment of TACE-refractory hepatocellular carcinoma than hepatic arterial infusion chemotherapy: a meta-analysis Shufeng Wang, Shasha Tang, Long Pan, XiuJun Cai Shufeng Wang Zhejiang University School of Medicine Sir Run Run Shaw

2020 Research Square

42. The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: A systematic review and meta-analysis Full Text available with Trip Pro

The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: A systematic review and meta-analysis The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: A systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary (...) version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level

2020 Research Square

43. Efficacy and safety of pregnant women with chronic hepatitis B receiving nucleos(t)ide analogs therapy: a network meta-analysis Full Text available with Trip Pro

Efficacy and safety of pregnant women with chronic hepatitis B receiving nucleos(t)ide analogs therapy: a network meta-analysis Efficacy and safety of pregnant women with chronic hepatitis B receiving nucleos(t)ide analogs therapy: a network meta-analysis | Research Square Browse Tools & Services Your Cart This preprint is under consideration at BMC Pregnancy and Childbirth . A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square (...) does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Efficacy and safety of pregnant women with chronic hepatitis B receiving nucleos(t)ide analogs therapy: a network meta-analysis Bo Zhu, Xiuli Chen, Fumin Feng, Erhei Dai Bo Zhu North China University of Science and Technology ORCiD

2020 Research Square

44. Statins in hepatitis B or C patients is associated with reduced hepatocellular carcinoma risk: a systematic review and meta-analysis Full Text available with Trip Pro

Statins in hepatitis B or C patients is associated with reduced hepatocellular carcinoma risk: a systematic review and meta-analysis Statins in hepatitis B or C patients is associated with reduced hepatocellular carcinoma risk: a systematic review and meta-analysis EISSN 2148-5607 Turkish Journal of Gastroenterology Toggle navigation Turkish Journal of Gastroenterology HIGHLY CITED ARTICLES By: Aydin, M. Merve; Akcali, Kamil Can By: Besheer, Tarek; Arafa, Mona M.; Abd El-Maksoud, Mohamed; et al (...) . By: Yilmaz, Ilkay; Dolar, M. Enver; Ozpinar, Haydar By: Demir, Meryem; Deyneli, Oguzhan; Yilmaz, Yusuf By: Tozlu, Mukaddes; Kayar, Yusuf; Ince, Ali Tuzun; et al. By: Bashiri, Mehrnoosh; Akcali, Didem; Coskun, Demet; et al. Statins in hepatitis B or C pa... Original Article Statins in hepatitis B or C patients is associated with reduced hepatocellular carcinoma risk: a systematic review and meta-analysis , , , , , , , 1. Department of Gastroenterology and Hepatology, Dongzhimen Hospital affiliated

2020 The Turkish Journal of Gastroenterology

45. Hepatitis E: symptoms, transmission, prevention, treatment

Hepatitis E: symptoms, transmission, prevention, treatment Hepatitis E: symptoms, transmission, prevention, treatment - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Hepatitis E: symptoms, transmission, prevention, treatment The symptoms, means of transmission, best means of prevention and treatment of hepatitis E. Published 1 June 2014 Last updated 16 July 2019 — From: Documents HTML Details (...) This document explains hepatitis E, describing the: symptoms means of transmission best means of prevention and treatment Published 1 June 2014 Last updated 16 July 2019 16 July 2019 Added provisional data for January to March 2019. 8 March 2019 Updated the number of hepatitis E cases in 2017 and 2018. 7 November 2018 Added provisional data for January to September 2018. 10 August 2018 Added provisional data for January to June 2018. 1 August 2018 Updated 2017 figures. 1 February 2018 Updated number

2020 Public Health England

46. Systematic review of the validity of the hepatitis B virus detection tests in blood banks from 2000 to 2018. Full Text available with Trip Pro

Systematic review of the validity of the hepatitis B virus detection tests in blood banks from 2000 to 2018. Systematic review of the validity of the hepatitis B virus detection tests in blood banks from 2000 to 2018 | bioRxiv Search for this keyword New Results Systematic review of the validity of the hepatitis B virus detection tests in blood banks from 2000 to 2018 Claudia Patricia Orrego-Marín , Jaiberth Antonio Cardona-Arias , Sandra Medina-Moreno , Juan Carlos Zapata doi: https://doi.org (...) , Baltimore, MD USA ; For correspondence: Abstract Background Hepatitis B Virus (HBV) is a public health problem that causes chronic hepatitis, eventually evolving to cirrhosis and hepatocellular carcinoma. Given the low frequency of screening in the general population, blood banks represent a key element for monitoring and controlling HBV transmission. The objective of this work was to evaluate the validity of the diagnosis of HBV in blood banks, based on studies published in the world scientific

2020 Cold Spring Harbor Laboratory

47. Faculty Opinions recommendation of Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis. Full Text available with Trip Pro

Faculty Opinions recommendation of Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis. Zinc supplementation in patients with cirrhosis and... | Faculty Opinions On April 12th, 2020, F1000Prime became Faculty Opinions. See our to learn more. Welcome Guest 1 Recommendations info_outline Systematic Review / Meta-analysis New Finding close Classified As New Finding 1 Article Type Systematic Review / Meta-analysis More more_vert close (...) Download article Export article Sciwheel Download citation BibTeX RIS Share Email Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis. ARTICLE PUBLISHED: 2019 07 06 CITE AS: Nutr J. 2019 07 06 ; 18 ( 1 ): 34 Recommendations Abstract Comments You have reached your article limit. Register for 30-day free trial Registration is free and only takes a moment, or subscribe for unlimited access. Already registered with Faculty Opinions? Sign

2020 Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

48. AASLD Guidelines for Treatment of Chronic Hepatitis B

AASLD Guidelines for Treatment of Chronic Hepatitis B Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance Norah A. Terrault, 1 Anna S.F. Lok, 2 Brian J. McMahon, 3 Kyong-Mi Chang, 4 Jessica P. Hwang, 5 Maureen M. Jonas, 6 Robert S. Brown Jr., 7 Natalie H. Bzowej, 8 and John B. Wong 9 Purpose and Scope of the Guidance This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016 Practice Guidelines for Treatment of Chronic (...) Hepatitis B (1) and update the previous hepatitis B virus (HBV) guidelines from 2009. The 2018 updated guidance on chronic hepatitis B (CHB) includes (1) updates on treatment since the 2016 HBV guidelines (notably the use of tenofovir alafenamide) and guidance on (2) screening, counseling, and prevention; (3) specialized virological and serological tests; (4) monitoring of untreated patients; and (5) treatment of hepatitis B in special populations, including persons with viral coin- fections, acute

2020 American Association for the Study of Liver Diseases

49. Screening for Hepatitis C Virus Infection

Screening for Hepatitis C Virus Infection Screening for Hepatitis C Virus Infection | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Screening for Hepatitis C Virus Infection Practice Advisory April 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . The on March 2, 2020. New guidance from both the CDC and the USPSTF represent a change in routine screening (...) for HCV; both organizations now recommend HCV screening for all adults, including pregnant and nonpregnant individuals. The American College of Obstetricians and Gynecologists (ACOG) is actively reviewing the new guidance from the CDC and USPSTF. Updated guidance from ACOG will be posted on ACOG’s website and published in Obstetrics & Gynecology when available. ACOG is also reviewing its current guidance on the screening and management of hepatitis for pregnant individuals in ACOG Practice Bulletin

2020 American College of Obstetricians and Gynecologists

50. Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis Full Text available with Trip Pro

Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should (...) not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis Yandi Xie, Rui Jin, Guangjun Song, Hui Ma, Bo Feng Yandi Xie Peking University People's Hospital ORCiD: https://orcid.org/0000-0001-5002-341X Rui Jin Peking University People's Hospital Guangjun Song Peking University People's Hospital Hui Ma

2020 Research Square

51. Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B, A protocol for systematic review and network meta-analysis Full Text available with Trip Pro

Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B, A protocol for systematic review and network meta-analysis Inplasy Protocol 16 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review Protocols

52. The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: A systematic review and meta-analysis Full Text available with Trip Pro

The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: A systematic review and meta-analysis The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: A systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary (...) version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level

2020 Research Square

53. Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis Full Text available with Trip Pro

Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should (...) not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis Yandi Xie, Rui Jin, Guangjun Song, Hui Ma, Bo Feng Yandi Xie Peking University People's Hospital ORCiD: https://orcid.org/0000-0001-5002-341X Rui Jin Peking University People's Hospital Guangjun Song Peking University People's Hospital Hui Ma

2020 Research Square

54. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. Full Text available with Trip Pro

Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing

2020 JAMA

55. Givosiran (Givlaari) - acute hepatic porphyria

Givosiran (Givlaari) - acute hepatic porphyria Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands An agency of the European Union Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. EMA/62114/2020 EMEA/H/C/004775 Givlaari (givosiran) An overview of Givlaari and why (...) it is authorised in the EU What is Givlaari and what is it used for? Givlaari is a medicine for treating acute hepatic porphyria in patients aged 12 years or over. Acute hepatic porphyria is a rare genetic condition in which the liver cannot properly produce a substance called haem. As a result, substances used to make haem build up in the body, causing attacks of severe abdominal pain, vomiting and nervous system disorders. Acute hepatic porphyria is rare, and Givlaari was designated an ‘orphan medicine

2020 European Medicines Agency - EPARs

56. Toolkit to support the generation of robust estimates of hepatitis C prevalence

Toolkit to support the generation of robust estimates of hepatitis C prevalence TECHNICAL REPORT Technical protocol for hepatitis C prevalence surveys in the general population SPHERE-C Project www.ecdc.europa.euECDC TECHNICAL REPORT Technical protocol for hepatitis C prevalence surveys in the general population SPHERE-C Project ii This report was commissioned by the European Centre for Disease Prevention and Control (ECDC), coordinated by Erika Duffell and Andrew Amato-Gauci, and produced (...) : European Centre for Disease Prevention and Control. Technical protocol for hepatitis C prevalence surveys in the general population. Stockholm: ECDC; 2020. Stockholm, February 2020 ISBN 978-92-9498-423-4 doi: 10.2900/30190 Catalogue number TQ-03-19-928-EN-N © European Centre for Disease Prevention and Control, 2019 Cover picture: © Science Photo Reproduction is authorised, provided the source is acknowledged. For any use or reproduction of photos or other material that is not under the EU copyright

2020 European Centre for Disease Prevention and Control - Technical Guidance

57. Phlebotomy resulting in controlled hypovolaemia to prevent blood loss in major hepatic resections (PRICE-1): a pilot randomized clinical trial for feasibility Full Text available with Trip Pro

Phlebotomy resulting in controlled hypovolaemia to prevent blood loss in major hepatic resections (PRICE-1): a pilot randomized clinical trial for feasibility Major liver resection is associated with blood loss and transfusion. Observational data suggest that hypovolaemic phlebotomy can reduce these risks. This feasibility RCT compared hypovolaemic phlebotomy with the standard of care, to inform a future multicentre trial.Patients undergoing major liver resections were enrolled between June

2020 EvidenceUpdates

58. Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care. Full Text available with Trip Pro

Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care. To evaluate the effectiveness and cost effectiveness of a complex intervention in primary care that aims to increase uptake of hepatitis C virus (HCV) case finding and treatment.Pragmatic, two armed, practice level, cluster randomised controlled trial and economic evaluation.45 general practices in South West England (22 randomised

2020 BMJ

59. Seroepidemiology of Hepatitis E Virus Infection in Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

Seroepidemiology of Hepatitis E Virus Infection in Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis Seroepidemiology of Hepatitis E Virus Infection in Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting (...) preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Seroepidemiology of Hepatitis E Virus Infection in Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis Ahmad Tavakoli, Seyed Moayed Alavian, Mohsen Moghoofei, Shayan Mostafaei, Saeedeh Abbasi, Mohammad Farahmand Ahmad Tavakoli Iran University of Medical

2020 Research Square

60. Hepatic arterial infusion chemotherapy versus Sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis Full Text available with Trip Pro

Hepatic arterial infusion chemotherapy versus Sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis Hepatic arterial infusion chemotherapy versus Sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research (...) Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research Hepatic arterial infusion chemotherapy versus Sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis guoqing ouyang, Guangdong Pan, Qiang Liu, Yongrong Wu, shengqiang Tan

2020 Research Square